News & Events

Welcome to Dalton Pharma Services News and Events.

On this page you will find our current and past news releases and a list of event happenings. If you can't find what you are looking for, please contact us and we will be happy to provide you with assistance.

11/22/2016 09:00 Dalton Pharma Services officially certified as a Great Place to Work

Dalton Pharma Services officially certified as a Great Place to Work following independently-conducted employee surveys

8/30/2016 18:25 Dalton Announces Completion of a Major Expansion in Sterile Filling and API Manufacturing

Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider to leading pharmaceutical and biotechnology companies, announced today the completion of a $5 million expansion in sterile filling and API manufacturing at its cGMP facility in Toronto, Canada.

2/17/2016 10:08 Dalton on FDA List of Registered Facilities for 2016
Dalton Pharma Services is now on the FDA list of registered facilities as an API manufacturing, testing and packaging facility for 2016.
2/3/2016 10:38 2016 CMO Leadership Award Won by Dalton Pharma Services

Dalton Pharma Services, a leading pharmaceutical cGMP contract manufacturing company, announced today that it has been selected by its clients to receive a 2016 CMO Leadership Award in all five core categories in the competition: Quality, Reliability, Capabilities, Expertise and Compatibility.

8/11/2015 20:00 Dalton Pharma Services Rated Compliant with New Health Canada API Regulations

Dalton Pharma Services today announced that a recent Health Canada inspection of its API manufacturing operations resulted in a “Compliant” rating against the newest Health Canada API manufacturing guidance.

7/7/2015 20:00 Dalton Pharma Services Announces Manufacturing and Development Agreement with Ramsey Lake Pharma

Dalton Pharma Services announces Agreement with Ramsey Lake Pharma for the synthesis and testing of VR23 to support their upcoming toxicology studies for their VR23 oncology candidate drug.

6/3/2015 20:00 Dalton Pharma Services Announces Manufacturing Agreement with Andes Biotechnologies

Dalton Pharma Services today announced the signing of a new service contract with Andes Biotechnologies to supply large molecule sterile dose manufacturing services for their Phase I/II clinical trials.

1/26/2015 19:00 Dalton Pharma Services Expands Sterile Powder Manufacturing Capabilities

Dalton Pharma Services today announced that it has expanded it cGMP sterile powder filling capabilities as part of its ongoing focus of sterile manufacturing, supported by FedDev Ontario funding.

12/1/2014 19:00 Dalton Announces the Launch of Steriles Made Simple(SM) Programs

Dalton Pharma Services announces the launch of its new Steriles Made SimpleSM Programs, designed to produce sterile liquid injectables for early phase clinical trials in as little as four months.

11/24/2014 19:00 Dalton Leads International Team Developing Novel Vaccines

Dalton awarded funding from ISTPCanada as part of an international vaccine development project under the 2013 Canada-China Joint Initiative on Human Vaccine Research and Development program.